CART-EGFR
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for CART-EGFR, covering 2015-09-29 to 2015-09-29. Get the full timeline:
Most recent: Clinical Trial Update: Treatment of Chemotherapy Refractory EGFR(Epidermal Growth Factor Receptor) Positive Advanced Solid Tumors (CART-EGFR) [Phase 1, Phase 2]